CN108504635A - A kind of culture medium for cultivating human adipose-derived stem cell - Google Patents

A kind of culture medium for cultivating human adipose-derived stem cell Download PDF

Info

Publication number
CN108504635A
CN108504635A CN201810597935.0A CN201810597935A CN108504635A CN 108504635 A CN108504635 A CN 108504635A CN 201810597935 A CN201810597935 A CN 201810597935A CN 108504635 A CN108504635 A CN 108504635A
Authority
CN
China
Prior art keywords
culture medium
cell
stem cell
culture
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810597935.0A
Other languages
Chinese (zh)
Inventor
李倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810597935.0A priority Critical patent/CN108504635A/en
Publication of CN108504635A publication Critical patent/CN108504635A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Abstract

The invention discloses a kind of culture medium for cultivating human adipose-derived stem cell, which is grouped as by following group：DMEM basal mediums, human serum albumins, transferrins, reduced glutathione, linoleic acid, penicillin, streptomysin, L glutamine, basic fibroblast growth factor, vitamin C and plant extract polypeptide composition.There is the culture medium of the present invention culture speed, cell to keep preferable integrality and activity.The culture medium can be used in large-scale cell culture, of low cost to facilitate preparation.

Description

A kind of culture medium for cultivating human adipose-derived stem cell
Technical field
The present invention relates to biotechnology, more particularly to a kind of culture medium of human adipose-derived stem cell.
Background technology
Fat stem cell (Adipose-derived stem cells, ADSCs) is to be detached from adipose tissue in recent years A kind of obtained stem cell with multi-lineage potential, has the characteristics that the general stem cell such as to expand, be not easy aging rapidly. Human adipose-derived stem cell, that is, body fat mescenchymal stem cell is be now widely used for organizational project and regenerative medicine field one Kind adult stem cell has multi-lineage potential as mesenchymal stem cell.ADSCs is grown in fibroblast sample, born of the same parents Slurry and kernel are abundant, are arranged in parallel or whirlpool sample.Cell cycle analysis shows that the cell of G0/G1 phases accounts for 69%, the S phases and accounts for 24%, the G2/M phase account for 8%.2-3 days 1 times of the cell Proliferations of secondary culture under the existence condition of fetal calf serum.Repeatedly passage (10- 20 generations) after, there is senile cell, the 15th generation cell mass after passing on 6 times without obviously slowing down in cell colony in cell proliferation rate Senile cell accounts for about 15% in body.
Since human adipose mesenchymal stem cells are separately cultured, the period is longer, about 2 weeks time that primary cell is paved with or more, reaches 3 weeks or so are needed to certain quantity.The passage of human adipose mesenchymal stem cells longterm culture in vitro is easy to happen Spontaneous Differentiation, loses Remove the potential of its Multidirectional Differentiation.So to ensure the continuity of experiment, it is necessary to provide a large amount of experiment or used in tissue engineering at any time Seed cell.Therefore, strongly for the demand of cell culture medium.
Currently used ADSCs cultures are trained with using the culture medium containing 10% fetal calf serum using feeder cells It supports.The shortcomings that this culture stem cell methods is method complexity, and the stem cell population of extraction is few, and purity is not high, and shoot proliferation is slow Slowly, it is more polluted the most important thing is being easy to cause stem cell using feeder cells and animal blood serum, it is especially potential in animal blood serum Animal derived endotoxin or virus will constitute health greatly risk, and the stem cell turned out in this way is unsuitable for directly answering For clinic.Therefore, a kind of suitable effective culture medium of exploitation becomes extremely urgent.
Invention content
The object of the present invention is to provide a kind of human adipose-derived stem cell culture mediums, overcome and prepare cell culture medium using serum Disadvantage and risk.In large-scale production, serum origin is more and more difficult, expensive, is to constitute animal cell culture to be produced into This one of major part.
The present invention provides one kind particularly suitable for human adipose-derived stem cell culture medium, which is grouped as by following group： DMEM basal mediums, human serum albumins, transferrins, reduced glutathione, linoleic acid, penicillin, streptomysin, L- paddy Glutamine, basic fibroblast growth factor, vitamin C and plant extract polypeptide composition.
Wherein, the specific dosage of each component is respectively penicillin 100IU/ml, 100 μ g/ml of streptomysin, L-Glutamine 2mmol/L, basic fibroblast growth factor l0ng/ml, 50 μ g/ml of vitamin C, 13 μ g/mL of human serum albumins turn A concentration of 10 μ g/mL of 6 μ g/mL of ferritin, reduced glutathione, linoleic acid con are 5 μ g/mL, 30 μ g/ of plant extract polypeptide ml。
The present invention additionally provides a kind of methods of culture human adipose-derived stem cell, including human adipose-derived stem cell are added to described Human adipose-derived stem cell culture medium the step of being cultivated.
The present invention additionally provides a kind of acquisition plant polypeptide, which extracts from the western wintergreen in natural plants river, Chuan Xi The evergreen herbelet shape fruticuli of wintergreen, blade is slightly plump glossy, and applicant, which speculates it just, stronger resistance to inverse and drought resisting Oxidation resistant effect.Applicant by detach the plant leaf blade by prepare protein pool functional analysis find, the plant extract Polypeptide has the effect of stablizing human adipose-derived stem cell, promoting stem cell growth, keep stem cell normal growth state.
The present invention additionally provides a kind of methods obtaining plant polypeptide, and (1) is clean by the western wintergreen leaf cleaning in river, twist It is broken, it squeezes the juice, papain and trypsase, enzyme concentration 15000IU/g blades, 45 DEG C of hydrolysis temperature, pH value 7.0, enzyme is added Time 2h is solved, 92 DEG C of enzyme deactivation 13min after the completion of enzymolysis；(2) material filtering after enzyme deactivation removes insoluble matter, obtains solution, gained 4% activated carbon adsorption decoloration is added in polypeptide solution, and peptide separation, 20mmol/ are carried out with glucan G-50 (Sephadex G-50) L HCl solutions elute, and flow velocity 1.3mL/ minute collects eluted product in different time periods respectively, adjusting solution to pH7.0, 10000 revs/min centrifuge 15 minutes, after macroreticular resin DA201-C desalting processings, are concentrated in vacuo, supernatant freeze-drying is standby With；Through sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the band of small-molecular-weight is recycled, wherein passing through Functional verification, the sequence that 27 small peptides are obtained have the function of promoting cell growth.According to peak value different in chromatographic column point From the time, corresponding small peptide can be obtained in batches, it also can the artificial synthesized polypeptide.The sequence of the polypeptide such as SEQ ID NO：Shown in 1-27.It is respectively designated as CXXDC-1~27.
The culture medium provide binding protein, polypeptides matter, vitamin participate in cell metabolism, can play supply nutrition, It neutralizes, the effect of removing toxic substances.The culture medium is free of animal blood serum, is free of potential animal derived endotoxin or virus in animal blood serum, It is convenient to be applied to clinic.
Specific implementation mode
Experimental method in following embodiments is unless otherwise instructed conventional method.Experiment utensil instrument reagent used It can all be obtained by commercial sources.
Embodiment 1:The culture medium for being not added with polypeptide is prepared
1) predetermined amount 1000mL is prepared, 900mL high glycoform DMEM cell culture fluids (producer is taken:Sigma), penicillin is added 100IU/ml, streptomysin 100 μ g/ml, L-Glutamine 2mmol/L, basic fibroblast growth factor l0ng/ml, dimension life 50 μ g/ml of plain C, human serum albumins 13 μ g/mL, 6 μ g/mL of transferrins, 10 μ g/mL of reduced glutathione, 5 μ of linoleic acid g/mL。
2) pH value is adjusted:PH to 7.0 is adjusted with 5%NaHCO3, with DMEM cell culture fluids constant volume to 1000ml.
3) filtration sterilization:Each one, upper layer 0.45um, lower layer 0.22um using 0.45um and 0.22um filter membranes, with Ensure filter effect.
The extraction of 2 polypeptide of embodiment
The western wintergreen leaf cleaning in river is clean, it rubs, squeezes the juice, papain and trypsase, enzyme concentration is added 15000IU/g blades, 45 DEG C of hydrolysis temperature, pH value 7.0, enzymolysis time 2h, 92 DEG C of enzyme deactivation 13min after the completion of enzymolysis；After enzyme deactivation Material filtering remove insoluble matter, obtain solution, 4% activated carbon adsorption decoloration is added in gained polypeptide solution, with glucan G-50 (Sephadex G-50) carries out peptide separation, the elution of 20mmol/L HCl solutions, and flow velocity 1.3mL/ minutes is collected different respectively The eluted product of period adjusts solution to pH7.0, and 10000 revs/min centrifuge 15 minutes, through macroreticular resin DA201-C desalinations It after processing, is concentrated in vacuo, supernatant freeze-drying is spare；Through sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- PAGE), the band of small-molecular-weight is recycled, wherein passing through functional verification, the sequence that 27 small peptides are obtained is fatty with people is stablized The effect of stem cell promotes stem cell growth, keeps stem cell normal growth state.According to peak separation different in chromatographic column Time can obtain corresponding small peptide in batches, also can the artificial synthesized polypeptide.The sequence of the polypeptide such as SEQ ID NO： Shown in 1-27.It is respectively designated as CXXDC-1~27.
The preparation of culture medium of the embodiment 3 containing polypeptide
1) predetermined amount 1000mL is prepared, 900mL high glycoform DMEM cell culture fluids (producer is taken:Sigma), penicillin is added 100IU/ml, streptomysin 100 μ g/ml, L-Glutamine 2mmol/L, basic fibroblast growth factor l0ng/ml, dimension life 50 μ g/ml of plain C, human serum albumins 13 μ g/mL, 6 μ g/mL of transferrins, 10 μ g/mL of reduced glutathione, 5 μ of linoleic acid 30 μ g/ml of g/mL, CXXDC-1 polypeptide.
2) pH value is adjusted:Use 5%NaHCO3PH to 7.0 is adjusted, with DMEM cell culture fluids constant volume to 1000ml.
3) filtration sterilization:Each one using 0.45um and 0.22um filter membranes, upper layer 0.45um, lower layer 0.22um.System Standby obtained culture medium is CXXDC-1 culture mediums.
According to above-mentioned identical method, the culture medium of CXXDC-2~27 is prepared respectively.
4 culture medium of the present invention of embodiment has blood serum medium culture and the comparison of effect with conventional
By 1X 106A fat stem cell is inoculated into 30 groups of diameter 100mm culture dishes for filling different culture mediums respectively In, every group of 10 culture dishes, mixing；Wherein first group-the 27 groups have 10 culture dishes respectively, and the training of CXXDC-2~27 is added Support base 5mL；
28th group of 10 culture dishes, culture medium mTeSR1 is added, and (purchase leads to Bioisystech Co., Ltd, article No. from Hangzhou hundred 05850)5mL；
High glycoform DMEM cell culture fluids 5mL is added in 29th group of 10 culture dishes；
The fat stem cell culture medium 5mL in 102732477 B patent documents of CN is added in 30th group of 10 culture dishes.
Cell is placed on and is cultivated in 37 DEG C, the incubator of 5%CO2；It is placed in inverted microscope observation, every 3 It sucks upper layer culture medium with pipette, and new culture medium is added, and continues to cultivate.
Cell count:It takes a culture dish to be put into clean bench in each group daily, then abandons culture with pipette suction Base.PBS is washed 2 times, and 1ml 0.25%Trypsin-EDTA are added and are added after finding attached cell separation under inverted microscope The basal medium that 4ml contains 10%FBS terminates pancreatin effect.Trypan blue (Typan Blue) staining blood cells tally counts Viable count, 10 wares are averaged.As a result as follows：
The experimental results showed that culture medium of the invention can effectively cultivate human adipose-derived stem cell.And cell growth is bent The S-shaped of line and the prior art is slightly different, almost 7 fonts, and the time into exponential phase is shorter, and the saturation of cell Concentration higher.Cell, which increases to slow down, later enters platform area, and the cell of apoptosis is not very much, maintains longer cytotostatic Phase.
5 cytomorphology of embodiment is analyzed
Cell after the peak period of Example 4 carries out microscope detection, finds 1-27 and 30 group of medium culture Cellular morphology it is identical.And the state of the cell presented premature differentiation of 28 29 groups of combinations.It takes thin after cultivating 10 days Born of the same parents, which detect, to be found, the cellular morphology of 1-27 groups is still intact, substantially seldom apoptosis cells.And 28 and 29 groups have more wither Cell is died, 30 groups of apoptotic cells for larger proportion also occur, this explanation, cell culture medium of the invention, which has, preferably keeps thin Born of the same parents' integrality and the function of maintaining cell activity.
6 surface antigen analysis of embodiment
The primary fat stem cell for taking 1-27 group medium cultures, removes culture solution, with 1:1 2.5% tryptose Enzyme solutions and 0.0296EDTA solution mixture slakings, every 100ul is made after being washed with the PBS containing 1% bovine serum albumin(BSA) (BSA) Contain 1X 1O6A single cell suspension is divided into 7 parts, is separately added into 7 Eppendorf pipes and numbers, and No.1 pipe is added altogether FITC Mouse IgGl, APC_CY7Mouse IgG2b and the dye solution of 20 μ L is for detecting due to antibody non-specificity As a contrast in conjunction with reasons for its use, other test tubes be separately added into CD29, CD34,44,45,105, HLA.DR monoclonal antibodies it is each 20 μ L, often pipe be separately added into 100 μ L (1O containing 1X of cell suspension6A cell), it is incubated at room temperature 25min, with the PBS containing 1%BSA After washing, flow cytomery.Analysis result:Flow cytometry analysis six kinds of surface antigens 29 of primary human adipose-derived stem cell, 34,44, CD45, CD105 and HLA.DR, the results showed that there is human adipose-derived stem cell using the cell that serum free medium is turned out Characteristic.HLA.DR is negative, and it is fibroblast to exclude such cell.
Above-described is only some embodiments of the present invention.For those of ordinary skill in the art, not Under the premise of the disengaging present invention makes design, several changes and improvements can also be made, these belong to the protection domain of invention.
Sequence table
<110>Li Qian
<120>A kind of culture medium for cultivating human adipose-derived stem cell
<160> 27
<170> SIPOSequenceListing 1.0
<210> 1
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 1
Pro His Val Thr Tyr Cys Ser Val Asp Ile Pro Asp Ser Trp Leu Lys
1 5 10 15
Ser Glu
<210> 2
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 2
Ile Trp Lys Trp Ala Arg Pro Leu Cys Trp Asn Trp His Met Gln Tyr
1 5 10 15
Met His
<210> 3
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 3
Arg Cys Trp Thr Ala Met Ser Leu Asp Pro Thr Pro Tyr Ser Asn Gly
1 5 10 15
Tyr Ala
<210> 4
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 4
Ala Met His Tyr His Phe Trp Ala His Lys Arg Gly Val Trp Tyr Phe
1 5 10 15
Trp Val
<210> 5
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 5
Arg Val Lys Trp Asn Asp Tyr Pro Gln His Glu Val Asn Asn Arg Arg
1 5 10 15
Pro Trp
<210> 6
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 6
Lys Tyr Leu Ser Gln Thr Glu His Lys Pro Ser Ala Thr Trp Ser Gln
1 5 10 15
Trp Pro
<210> 7
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 7
Ala Gln Gly Arg Thr His Gly Gln Lys Arg Thr Ser Thr Trp Pro Arg
1 5 10 15
Val
<210> 8
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 8
His Val Gln Thr Val Glu Gly Leu Gly Met Pro Gln Arg Arg Thr Pro
1 5 10 15
<210> 9
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 9
Gln Val Phe Ala His Gln Gln Met Glu Lys Thr Gly Met Val Gln Arg
1 5 10 15
Gly
<210> 10
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 10
Arg Gly Pro Gln Arg Ala Trp Thr Glu Gly Pro Ser Cys Ile Lys Arg
1 5 10 15
<210> 11
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 11
Gly Pro Arg Gly Ile Ser Ile Ser Ser Ser Gln Arg Arg Ala Gly Asn
1 5 10 15
Pro
<210> 12
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 12
Pro Val Lys Trp Gln Arg Arg Arg Thr His Gln Met Phe Lys Trp Cys
1 5 10 15
<210> 13
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 13
Gly Gln Met Lys Trp Asp Gly Tyr Ile Asn Pro Tyr Asp Arg Pro Thr
1 5 10 15
Lys
<210> 14
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 14
Met Pro Pro Gly Pro Gln Gln Met Arg Gln Gly Met Ser Arg Asp Gln
1 5 10 15
<210> 15
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 15
Pro Lys Gly Pro Ser Ser Thr Gly His Phe Lys Gly Gln Asp Ala Met
1 5 10 15
Tyr
<210> 16
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 16
Trp Trp Ser Asp Lys Gln Leu Phe Trp Leu Gln Phe Gln Gln Ser Cys
1 5 10 15
<210> 17
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 17
Asp Ser Met Thr Met Gly Asn Cys His Thr Gly Trp Val Gly Arg His
1 5 10 15
Thr
<210> 18
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 18
Ala Ser Thr Trp Cys Arg Val Pro Gln Trp Phe Ser His Ser Cys Thr
1 5 10 15
<210> 19
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 19
Lys His Phe Tyr Gln Arg Trp Gln Ile Glu Gly Ser Gly Pro Phe Pro
1 5 10 15
Met Lys
<210> 20
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 20
Pro Gly Asp Thr Val Ile Lys Tyr Met Gly Pro Tyr Cys Arg Gln Glu
1 5 10 15
Asp
<210> 21
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 21
Glu Leu Ala Gly Ala Ile Glu Leu Gly Arg Glu Trp Gln Val Lys Met
1 5 10 15
<210> 22
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 22
Met Gln Phe His Leu Asp Pro Phe Gly Asp Arg Gly Asn Arg Glu Thr
1 5 10 15
Val Ala
<210> 23
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 23
Tyr Val Phe Glu Glu Gly Thr Glu Trp Pro Trp Asn Cys Lys Ser Tyr
1 5 10 15
Ser
<210> 24
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 24
Thr Ser Leu His Pro His Arg Asn Leu His Phe Gln Arg Ser Val Gln
1 5 10 15
<210> 25
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 25
Leu Ile Val Pro His Pro Ile Asn Met Lys Gln Met Asn Arg Thr Ile
1 5 10 15
Trp Asn
<210> 26
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 26
Thr Tyr Glu Asn Asp Val Pro Ser His Met Glu Asp Gln Gly His Pro
1 5 10 15
Tyr
<210> 27
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 27
Arg His Asn His Pro Ser Lys Leu Trp Lys Ala Arg Arg Asn Asn Gly
1 5 10 15

Claims (4)

1. a kind of culture medium for human adipose-derived stem cell culture, the culture medium is on the basis of high glycoform DMEM cell culture fluids Penicillin 100IU/ml, streptomysin 100 μ g/ml, L-Glutamine 2mmol/L, basic fibroblast growth factor is added L0ng/ml, 50 μ g/ml of vitamin C, 13 μ g/mL of human serum albumins, transferrins 6 μ g/mL, 10 μ of reduced glutathione G/mL, 5 μ g/mL of linoleic acid and 30 μ g/ml compositions of polypeptide.
2. culture medium as described in claim 1, which is characterized in that the polypeptide such as SEQ ID NO：Shown in 14.
3. claim 1-2 any one of them culture medium is for cultivating the purposes in human adipose-derived stem cell.
4. a kind of polypeptide, sequence such as SEQ ID NO：Shown in 14.
CN201810597935.0A 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell Pending CN108504635A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810597935.0A CN108504635A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810597935.0A CN108504635A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201610123460.2A CN105586311B (en) 2016-03-06 2016-03-06 It is a kind of for cultivating the culture medium of human adipose-derived stem cell

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201610123460.2A Division CN105586311B (en) 2016-03-06 2016-03-06 It is a kind of for cultivating the culture medium of human adipose-derived stem cell

Publications (1)

Publication Number Publication Date
CN108504635A true CN108504635A (en) 2018-09-07

Family

ID=55926219

Family Applications (27)

Application Number Title Priority Date Filing Date
CN201810597529.4A Pending CN108410813A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597086.9A Pending CN108441468A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201610123460.2A Active CN105586311B (en) 2016-03-06 2016-03-06 It is a kind of for cultivating the culture medium of human adipose-derived stem cell
CN201810598047.0A Pending CN108486052A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597030.3A Pending CN108410810A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597935.0A Pending CN108504635A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597526.0A Pending CN108441470A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597487.4A Pending CN108441469A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597489.3A Pending CN108504630A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597504.4A Pending CN108410812A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597973.6A Pending CN108410818A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597029.0A Withdrawn CN108441467A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810596766.9A Withdrawn CN108410807A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597875.2A Pending CN108410814A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597958.1A Pending CN108410816A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810596768.8A Withdrawn CN108410808A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597933.1A Pending CN108504634A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597917.2A Pending CN108504632A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597416.4A Pending CN108504629A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597505.9A Pending CN108504631A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597932.7A Pending CN108504633A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597459.2A Pending CN108410811A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597957.7A Pending CN108410815A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810596781.3A Withdrawn CN108410809A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597969.XA Pending CN108410817A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597975.5A Pending CN108410819A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810598043.2A Pending CN108486051A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell

Family Applications Before (5)

Application Number Title Priority Date Filing Date
CN201810597529.4A Pending CN108410813A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597086.9A Pending CN108441468A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201610123460.2A Active CN105586311B (en) 2016-03-06 2016-03-06 It is a kind of for cultivating the culture medium of human adipose-derived stem cell
CN201810598047.0A Pending CN108486052A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597030.3A Pending CN108410810A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell

Family Applications After (21)

Application Number Title Priority Date Filing Date
CN201810597526.0A Pending CN108441470A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597487.4A Pending CN108441469A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597489.3A Pending CN108504630A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597504.4A Pending CN108410812A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597973.6A Pending CN108410818A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597029.0A Withdrawn CN108441467A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810596766.9A Withdrawn CN108410807A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597875.2A Pending CN108410814A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597958.1A Pending CN108410816A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810596768.8A Withdrawn CN108410808A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597933.1A Pending CN108504634A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597917.2A Pending CN108504632A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597416.4A Pending CN108504629A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597505.9A Pending CN108504631A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597932.7A Pending CN108504633A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597459.2A Pending CN108410811A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597957.7A Pending CN108410815A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810596781.3A Withdrawn CN108410809A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597969.XA Pending CN108410817A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810597975.5A Pending CN108410819A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell
CN201810598043.2A Pending CN108486051A (en) 2016-03-06 2016-03-06 A kind of culture medium for cultivating human adipose-derived stem cell

Country Status (1)

Country Link
CN (27) CN108410813A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107056896B (en) * 2017-06-05 2020-05-26 沃昕生物科技(深圳)有限公司 Polypeptide and culture medium containing polypeptide
CN107475188A (en) * 2017-09-25 2017-12-15 广东颜值科技有限公司 A kind of cultural method of cell culture medium and embryonic stem cell
CN107686827B (en) * 2017-10-30 2018-11-16 集钧（上海）医疗科技发展有限公司 Human adipose-derived stem cell special media
CN109966500B (en) * 2019-04-19 2022-12-30 宁夏医科大学总医院 Wolfberry polysaccharide-containing protective solution and application method thereof in improving pathological microenvironment of mesenchymal stem cells in vivo
CN110713974A (en) * 2019-11-25 2020-01-21 深圳科学之门生物工程有限公司 Stem cell culture medium and preparation method thereof
CN112011505B (en) * 2020-09-09 2021-07-30 陕西中港万海生命科学研究院有限公司 Umbilical cord mesenchymal stem cell separation method
CN112831465A (en) * 2021-01-12 2021-05-25 上海南滨江细胞生物科技有限公司 Culture method of autologous adipose-derived stem cells for treating central nervous system injury
CN114181897A (en) * 2021-11-30 2022-03-15 东莞市麦亘生物科技有限公司 Construction method of anti-aging autologous stem cell model

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102433299B (en) * 2011-11-17 2013-01-23 安徽农业大学 Method for separating, culturing and purifying mouse adipose-derived stem cells
CN102732477B (en) * 2012-06-15 2013-06-19 江苏瑞思坦生物科技有限公司 Human adipose-derived stem cell serum-free basic medium
CN103255103B (en) * 2013-04-17 2015-01-14 冯文峰 Serum-free adipose tissue-derived mesenchymal stem cell culture medium
CN104877962A (en) * 2015-04-15 2015-09-02 广州赛莱拉干细胞科技股份有限公司 Serum-free adipose-derived stem cell culture medium and preparation method thereof

Also Published As

Publication number Publication date
CN108410818A (en) 2018-08-17
CN108410810A (en) 2018-08-17
CN108486052A (en) 2018-09-04
CN108410813A (en) 2018-08-17
CN108441470A (en) 2018-08-24
CN108504632A (en) 2018-09-07
CN108410817A (en) 2018-08-17
CN108504629A (en) 2018-09-07
CN108441469A (en) 2018-08-24
CN108410807A (en) 2018-08-17
CN108504630A (en) 2018-09-07
CN108504631A (en) 2018-09-07
CN108441467A (en) 2018-08-24
CN108410814A (en) 2018-08-17
CN108486051A (en) 2018-09-04
CN105586311B (en) 2019-02-22
CN108410819A (en) 2018-08-17
CN108410815A (en) 2018-08-17
CN108504633A (en) 2018-09-07
CN108410812A (en) 2018-08-17
CN108441468A (en) 2018-08-24
CN108410816A (en) 2018-08-17
CN108410808A (en) 2018-08-17
CN105586311A (en) 2016-05-18
CN108410809A (en) 2018-08-17
CN108410811A (en) 2018-08-17
CN108504634A (en) 2018-09-07

Similar Documents

Publication Publication Date Title
CN105586311B (en) It is a kind of for cultivating the culture medium of human adipose-derived stem cell
CN105494317B (en) A kind of cells frozen storing liquid of human adipose-derived stem cell
CN104593317B (en) A kind of soybean active peptide addition for cell culture medium
WO2020233119A1 (en) Serum-free polypeptide composition for promoting proliferation of mesenchymal stem cells
CN107418930A (en) A kind of preparation method purified with amplification human marrow mesenchymal stem cell
CN110564675A (en) Separation and extraction method of hair follicle stem cells
CN107686827B (en) Human adipose-derived stem cell special media
CN106834217A (en) A kind of method for promoting human amnion membrane amplification in vitro and application
CN108495924A (en) Method for generating mescenchymal stem cell
CN104726400A (en) Animal-source-free component culture method for differentiation from human pluripotent stem cells to germ cells
TW202214843A (en) Methods for promoting proliferation and propagation of stem cells
CN110218699A (en) Fat stem cell fast culture and differentiation method
CN108165600A (en) The method that phycocyanin is extracted from spirulina
CN106434546A (en) Method for preparing mesenchymal stem cell by fully utilizing umbilical cord resources
CN102586201A (en) Preparation method of recombinant human thioredoxin
CN114381424A (en) Method for promoting proliferation and reproduction of stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180907